To ask the Secretary of State for Business, Energy and Industrial Strategy, whether his Department plans to reinvest any investment recouped from the sale of Vaccine Manufacture and Innovation Centre into life sciences.
6 January 2022
Officials are working closely with VMIC and other third parties to ensure that the UK retains a strong domestic vaccine manufacturing capability to contribute to our response to COVID-19 and resilience to other future health emergencies. We believe VMIC will play an important role in the UK’s vaccine ecosystem. At present, these discussions are commercially sensitive.